[Theories on the models of action of antipsychotic drugs]

Cluster, facets, and edges: site-dependent selective chemistry on model catalysts.

Chemical record (New York, N.Y.)·2003

Partial dopamine agonists and dopaminergic stabilizers, in the treatment of psychosis.

Current drug targets. CNS and neurological disorders·2003

Identification of a susceptibility locus for migraine with and without aura on 6p12.2-p21.1.

Neurology·2002

A half-century of neurotransmitter research: impact on neurology and psychiatry. Nobel lecture.

Bioscience reports·2002

A prospective randomised trial of internal fixation versus arthroplasty for displaced fractures of the neck of the femur. Functional outcome for 450 patients at two years.

The Journal of bone and joint surgery. British volume·2002

Tissue transglutaminase autoantibodies and human leucocyte antigen in Down's syndrome patients with coeliac disease.

Acta paediatrica (Oslo, Norway : 1992)·2002

Surgical management of acute cholecystitis in Norway - a registry study.

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2026

Neonatal abstinence syndrome in Norway - a registry study.

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2026

The PHLPP paradox revisited: from canonical AKT phosphatases to signaling pseudoenzymes in human disease.

Biochemical pharmacology·2026

Pironetin Preferentially Inhibits Microtubule Minus-End Growth and Enables Polarity Marking.

Biochemistry. Biokhimiia·2026

Deciphering the therapeutic mechanisms of Pluchea lanceolata in Rheumatoid arthritis (RA) using network pharmacology, molecular docking and in silico molecular dynamics simulations.

In silico pharmacology·2026

PepRePs: Peptide-Retargeted Phosphatases Designed with Generative Language Models.

bioRxiv : the preprint server for biology·2026

Centanafadine: First Approval.

Drugs·2026

Reciprocal blockade of the opioid and D2-like dopamine receptors in the nucleus accumbens modulates the pain-related behaviors in an animal model of inflammatory pain.

Behavioural pharmacology·2026

Related Experiment Videos

[Theories on the models of action of antipsychotic drugs]

Related Concept Videos

Cluster, facets, and edges: site-dependent selective chemistry on model catalysts.

Partial dopamine agonists and dopaminergic stabilizers, in the treatment of psychosis.

Identification of a susceptibility locus for migraine with and without aura on 6p12.2-p21.1.

A half-century of neurotransmitter research: impact on neurology and psychiatry. Nobel lecture.

A prospective randomised trial of internal fixation versus arthroplasty for displaced fractures of the neck of the femur. Functional outcome for 450 patients at two years.

Tissue transglutaminase autoantibodies and human leucocyte antigen in Down's syndrome patients with coeliac disease.

Surgical management of acute cholecystitis in Norway - a registry study.

Neonatal abstinence syndrome in Norway - a registry study.

The PHLPP paradox revisited: from canonical AKT phosphatases to signaling pseudoenzymes in human disease.

Pironetin Preferentially Inhibits Microtubule Minus-End Growth and Enables Polarity Marking.

Deciphering the therapeutic mechanisms of Pluchea lanceolata in Rheumatoid arthritis (RA) using network pharmacology, molecular docking and in silico molecular dynamics simulations.

PepRePs: Peptide-Retargeted Phosphatases Designed with Generative Language Models.

Centanafadine: First Approval.

Reciprocal blockade of the opioid and D2-like dopamine receptors in the nucleus accumbens modulates the pain-related behaviors in an animal model of inflammatory pain.

Related Experiment Videos

[Theories on the models of action of antipsychotic drugs]

Related Concept Videos

Related Articles